Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: Case was appealed twice (rare);the last was split 5 to 5; important to T3 vs TPL

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

Case was appealed twice (rare);the last was split 5 to 5; important to T3 vs TPL

MIKE6553

Jul 16, 2012 03:07PM

BostonCA

Rank: Treasurer [?]

Points: 1252 [?]

Votes: 48 Score: 2.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Case was appealed twice (rare);the last was split 5 to 5; important to T3 vs TPL

in response to

Case was appealed twice (rare);the last was split 5 to 5; important to T3 vs TPL

MIKE6553

posted on Jul 16, 2012 06:32PM

I don't understand?

Reply New Message

Back To Forum List View

Please to post a reply